News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Conference News TCT 2020 Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate Shelley Wood October 14, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Daily News Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI Yael L. Maxwell October 03, 2017
News Conference News ESC 2017 Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART Shelley Wood August 27, 2017
News Daily News Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin Todd Neale March 07, 2017
News Daily News Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell November 11, 2016
News Daily News Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias Yael L. Maxwell November 11, 2016
News Daily News Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected? Yael L. Maxwell July 27, 2016
News Daily News Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests Yael L. Maxwell June 20, 2016
News Daily News Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion Shelley Wood April 18, 2016
News Daily News La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada Shelley Wood April 18, 2016
News Daily News Complicaciones en el Laboratorio de Cateterización: Un Nuevo Análisis Define el Índice y Riesgos de los Episodios Trombóticos Intraoperatorios en el Manejo del SCA Shelley Wood January 21, 2016
News Daily News Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS Shelley Wood January 21, 2016
News Conference News ESC 2015 MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI Yael L. Maxwell September 02, 2015
News Daily News BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI April 03, 2015